Tissue Regenix Group plc is an international medical technology company based in the UK. The company focuses on developing regenerative products using its two platform technologies, such as dCell and BioRinse. The dCell platform addresses soft tissue needs and the BioRinse platform provides sterile bone allography. Its divisions include dCELL, BioRinse and GBM-V. dCell technology removes deoxyribonucleic acid (DNA) and other cell material from animal and human soft tissue, leaving behind an acellular tissue scaffold that is not rejected by the patient’s body and can then be used to repair diseased or damaged body parts. Its BioRinse technology is primarily used to provide natural bone fillers, proven for osteoinductivity, that can stimulate and regenerate a person’s bone growth. His CellRight Technologies is involved in the development of osteoinductive and soft tissue scaffolds that improve the healing ability of defects resulting from trauma and disease.
Learn more about the company
“Coffee trailblazer. Analyst. General music geek. Bacon maven. Devoted organizer. Incurable internet ninja. Entrepreneur.”
